Beware These 10 Biopharma “High-Beta Bombs”
Avoid the market’s most volatile stocks, advises the author of today’s article. In fact, he refers to the market’s top 10% or top 20% most…
Avoid the market’s most volatile stocks, advises the author of today’s article. In fact, he refers to the market’s top 10% or top 20% most…
“These are four stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s…
The FDA’s approval of Biogen’s Alzheimer’s drug “has set a precedent, showing a much easier path to approval for investigative drug treatments focused on neurodegenerative…
With the current excitement surrounding heavily shorted stocks, the author of today’s article takes a look at a number of current and former penny stocks…
Against a backdrop in which investors remain keen on COVID-19 vaccine stocks such as Moderna and Novavax, and in which Biogen has just received the…
There’s a new type of revolutionary science on the horizon: proteomics. But just what is proteomics – and what do healthcare investors need to know…
A regenerative medicine company focused on developing, manufacturing and commercializing product solutions for the advanced wound care, surgical, and sports medicine markets in the U.S.…
“With West Texas Intermediate (WTI) crude trading near the $70 a barrel level, and expected to go even higher this summer, these stocks could have…
What makes the biotech stock featured in today’s article a buy according to an analyst who recently initiated coverage of it? The potential for its…
“Now that the global vaccination drive is in full flight, biotech companies are working on their research and development projects to advance new therapies to…